| Title |
Patient Perspectives of Dabigatran: Analysis of Online Discussion Forums
|
|---|---|
| Published in |
The Patient - Patient-Centered Outcomes Research, September 2013
|
| DOI | 10.1007/s40271-013-0027-y |
| Pubmed ID | |
| Authors |
Mary S. Vaughan Sarrazin, Peter Cram, Alexandur Mazur, Melissa Ward, Heather Schacht Reisinger |
| Abstract |
In 2010 the US FDA approved dabigatran, the first new anticoagulant for stroke prevention in non-valvular atrial fibrillation (AF) since 1954. To date there is little data that reflects the experiences and perceptions of real-world patients with dabigatran. The abundance of Internet-based discussion forums and support groups related to AF or anticoagulation may provide a low-cost resource for assessing patient experiences. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 42% |
| Canada | 2 | 17% |
| New Zealand | 2 | 17% |
| United States | 1 | 8% |
| Unknown | 2 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Scientists | 2 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Egypt | 1 | <1% |
| Slovenia | 1 | <1% |
| Denmark | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 153 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 18% |
| Researcher | 23 | 15% |
| Student > Ph. D. Student | 18 | 11% |
| Student > Bachelor | 15 | 9% |
| Student > Doctoral Student | 11 | 7% |
| Other | 24 | 15% |
| Unknown | 38 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 28% |
| Psychology | 15 | 9% |
| Social Sciences | 9 | 6% |
| Nursing and Health Professions | 7 | 4% |
| Business, Management and Accounting | 6 | 4% |
| Other | 30 | 19% |
| Unknown | 47 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2013.
All research outputs
#5,849,197
of 23,999,200 outputs
Outputs from The Patient - Patient-Centered Outcomes Research
#184
of 549 outputs
Outputs of similar age
#47,379
of 201,508 outputs
Outputs of similar age from The Patient - Patient-Centered Outcomes Research
#3
of 6 outputs
Altmetric has tracked 23,999,200 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 549 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,508 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.